Enhance your practice with CME and tools that focus on the management of neurological conditions.
More Than a Myopathy: The Lived Experience of TK2d
ADHD After 25 Years: What Have We Learned?
James Swanson, PhD
What’s Still Missing in ADHD Care?
ADHD Medication Dose-Effect Patterns Vary by Age and Drug Class
When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
Dani Cabral, MD
David Weisman, MD
Exploring the Potential Role of Emerging Muscarinic Therapies in the Treatment of Bipolar Disorder
Jose M. Rubio, MD, PhD
Sunny X. Tang, MD
Navigating the Limitations of Current BD Therapies
Emerging Perspectives: The Potential Role of Xanomeline Trospium Across the Bipolar Spectrum
Advancing Treat-to-Target Care in Generalized Myasthenia Gravis: Earlier Diagnosis, Standardized Assessment, and Precision Use of FcRn-Directed Therapy
Multiple dates & locations available
Stroke-Like Symptoms During Treatment: Safety First
Talking Through Benefits, Risks, and Patient Priorities
Borderline Biomarkers: When a Blood Test Is Not Enough
Outcome Measures Capture Progression in Late-Onset TK2d
Diagnosing Adult ADHD in the Social Media Era
Jill RachBeisel, MD
Modulating the Bipolar Circuit: Striatal Dopamine and the Muscarinic Opportunity
Recurrence as the Rule: BD Symptoms Persist and Cycle
ADHD Is Linked to a Broad Burden of GI Symptoms
Untangling ADHD from Depression, Anxiety, and Substance Use Disorder
Managing MAPK Inhibitor Adverse Events in Pediatric Low-Grade Gliomas
Alexandria May, PharmD, BCPS
Shannon Raber, MS, CPNP, RN
Bridget Archambault, MSN, CPNP
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.